Atlas Trials

Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7

Clinical trial NCT02040402 · COMPLETED

Trial details

NCT number
NCT02040402
Sponsor
The University of Hong Kong
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Infectious Disease
Start date
2009-02-01
Primary completion
2010-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.